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Abstract 
This article examines (1) the extent to which managed care participation is associated with 
technical efficiency in outpatient substance abuse treatment ( OSAT) organizations and (2) the con- 
tributions of specific managed care practices as well as other organizational, financial, and environ- 
mental attributes to technical efficiency in these organizations. Data are from a nationally represen- 
tative sample survey of  OSAT organizations conducted in 1995. Technical efficiency is modeled 
using data envelopment analysis. Overall, there were few significant associations between managed 
care dimensions and technical efficiency in outpatient treatment organizations. Only one managed 
care oversight procedure, the imposition of sanctions by managed care firms, was significantly asso- 
ciated with relative efficiency of these provider organizations. However, several organizational fac- 
tors were associated with the relative level of  efficiency including hospital affiliation, mental health 
center affiliation, JCAHO accreditation, receipt of lump sum revenues, methadone treatment modal- 
ity, percentage clients unemployed, and percentage clients who abuse multiple drugs. 
Managed care is steadily gaining acceptance as a financing and service delivery approach capable 
of  controlling the rapidly increasing costs in mental health and substance abuse services. 13 The pri- 
mary mechanism underlying cost reduction in managed care is limiting use of  services thought to be 
unnecessary for the effective treatment of  mental health or substance abuse problems. Whereas the 
cost savings from decreased use of  services can be documented relatively easily, 4 managed care also 
is argued to encourage providers to improve the efficiency with which care is delivered. However, 
the relationship between managed care and the technical efficiency of  providers has received little 
attention in empirical studies and policy debates. This study uses data envelopment analysis to ex- 
amine the association of  managed care practices; other organizational, financial, and environmental 
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factors; and the technical efficiency of organizations that deliver outpatient substance abuse treat- 
ment (OSAT), 
The specific aims of this article are (1) to describe the extent to which managed care participation 
is associated with technical efficiency in OSAT organizations and (2) to identify the contributions of 
specific managed care practices as well as other organizational, financial, and environmental attrib- 
utes to technical efficiency in these organizations. Because the limited knowledge of managed care 
and its effects to date stems largely from the inability of past research to address the complexity and 
diversity of managed care arrangements, this study tests the effects of multiple dimensions of man- 
aged care oversight on the technical efficiency in OSAT units. Results of the study are intended to 
provide policy makers and OSAT administrators with evidence regarding how specific managed 
care practices affect the technical efficiency in treatment organizations. 
Conceptual Model 
There is a growing body of literature regarding the effects of managed care on health care costs. 47 
However, several limitations characterize this research. 2 For example, although net cost reductions 
stemming from utilization review by a health maintenance organization may benefit an employer, 
some costs may be shifted to others including patients, their families, and providers. This study is 
concerned with one mechanism by which cost savings may be gained or lost under managed care: 
technical efficiency in the production of outpatient drug abuse treatment services. 
For purposes of this article, managed care is defined as a set of public or private programs 
designed to control access to care, types of care delivered, or the amount and/or costs of care. Such 
programs incorporate a set of oversight activities used by, or on behalf of, purchasers of health care 
benefits to influence patient care decision making as it affects the aforementioned areas. 5'g Technical 
efficiency is defined as the use of specific input resources (e.g., staff hours and expenses) by an 
OSAT facility to provide specific outputs (e.g., therapy hours). A treatment organization is said to be 
technically efficient when it produces the maximum possible sustained output from a given set of 
inputs. 9 
Decisions that affect the relative efficiency with which a unit produces outpatient substance abuse 
therapy are potentially influenced by an array of factors. This study proposes that technical effi- 
ciency in provider organizations will be affected by managed care participation and managed care 
oversight requirements imposed on the provider organization as well as by other critical organiza- 
tional, financial, and environmental factors. The rationales for these components of the conceptual 
model are discussed in the following sections. 
Managed Care Participation and Oversight 
As managed care firms seek to reduce costs, there are several ways in which provider organiza- 
tions may be affected, z8"~13 These include fewer authorizations for inpatient treatment, shorter 
lengths of outpatient treatment, and reductions in the level of payments to providers. Managed care 
firms often emphasize case management, use patient assessment criteria and treatment protocols, 
and have rigorous standards for the documentation of treatment outcomes. 
In practice, this means that OSAT units may be forced to provide shorter treatment programs, hire 
particular types of professional treatment staff, offer more group treatment, deemphasize or elimi- 
nate special programs, and better document treatment and follow-up to survive in the managed care 
environment. Managed care may, therefore, be associated with the technical efficiency of OSAT 
units in at least two ways. First, in light of the previous discussion about managed care, whether or 
not an OSAT unit participates in managed care may affect the technical efficiency of that organiza- 
tion. Second, among those organizations that do participate in managed care, technical efficiency 
may vary as a function of the scope and stringency of the activities used to manage care and costs. 
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These activities, hereinafter referred to as managed care oversight procedures, will likely modify 
technical efficiency as a unit adjusts staffing allocations and therapy structure to meet managed care 
requirements and guidelines. 
Managed care oversight refers to the mechanisms or controls imposed by the managed care 
organization on the provider to ensure that care is consistent with objectives of the managed care 
organization or its maj or clients. Generally, these procedures serve to control access to care and/or to 
regulate the amount, type, or quality of care. g Managed care oversight activities may have both posi- 
tive and negative effects on the technical efficiency of OSAT providers. 
Because they are focused on treatment processes rather than treatment outcomes, managed care 
oversight activities have the potential to increase the technical efficiency of provider organizations. 
For example, treatment plans and utilization review may encourage the efficient use of treatment 
resources by mandating shorter treatment duration and requiring more coordination of the treatment 
process. Furthermore, it is generally accepted that variability in provider behavior is a source of inef- 
ficiency in the delivery of health services.54 As managed behavioral care firms reduce the variability 
in outpatient drug abuse treatment practices, they may improve the technical efficiency of treatment 
organizations. 
Alternatively, however, managed care oversight procedures may decrease the technical efficiency 
of OSAT organizations in several ways. First, a reduction in the efficiency of organizational opera- 
tions often occurs when behavioral controls are removed from the site of production. ~s This may be 
true for OSAT providers because oversight requirements emanate from managed care firms that are 
physically removed from the site of service delivery. Second, managed care oversight activities often 
limit the range of services that are provided to clients (e.g., only group therapy) or specify the 
sequence of treatment options. Consequently, providers may lack the flexibility to treat clients in the 
most efficient manner. Finally, managed care oversight activities may increase requirements for 
administrative, accounting, or clerical record keeping on the part of the providers. In small organiza- 
tions, these requirements might represent a burden that increases the inefficiency with which care is 
provided. ~6 
In addition to managed care participation, this study considers five managed care oversight activi- 
ties and examines their association with technical efficiency. Each is discussed briefly in the 
following. 
Specification of  the treatmentplan. Some managed care organizations dictate the content of treat- 
ment plans to the provider. 17 Such requirements typically are imposed to allocate resources effi- 
ciently or to ensure that the level of quality of care is consistent with its cost. 
Written utilization review. Utilization review includes pre-certification and ongoing authoriza- 
tion requirements that involve the approval of services before they are delivered or review of care at 
regular intervals.18 In such review, managed care organizations typically examine appropriateness of 
type and intensity of care for the patient's condition, judge the efficacy of the proposed treatment, 
and/or weigh issues such as medical necessity and client response to treatment. 
Correspondence with treatment team member. The ease of handling the demands of managed 
care may vary as a function of who may communicate with the managed care organization for the 
purposes of utilization review. 17 Some managed care arrangements require such communication to 
be with a member of the treatment team. 
Visit limits. During the assessment and initial utilization review process, managed care arrange- 
ments may limit the number of visits or sessions authorized for payment. 17 Provider organizations 
must demonstrate client progress or document more severe client problems for additional visits to be 
approved. These visit limits may hinder the ability of treatment staff to design the most efficient and 
effective course of treatment for managed care clients. 
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Imposition of  sanctions. Some managed care arrangements may review cases retrospectively and 
determine that certain services are not covered or exceed established limits or that services provided 
were not consistent with their objectives regarding cost or quality. Managed care firms may impose 
sanctions on providers by not paying for services if oversight requirements were not met or were not 
followed in a timely fashion. 
Other Internal and External Factors 
Associated with Technical Efficiency 
Organizational Factors 
There exists significant variety in the respective affiliations and organizational structures of sub- 
stance abuse treatment organizations. In this analysis, five organizational factors are examined: 
organizational setting, methadone treatment, ownership, accreditation, provision of nontherapeutic 
services, and client severity. Treatment units may be organized as freestanding programs or affiliated 
with larger institutions such as mental health centers and hospitals. Units also may practice varying 
treatment modalities such as the provision of methadone versus drug-free treatment. To the extent 
that such differences in staffing patterns and treatment practices influence the resource requirements 
for service delivery, they are likely to affect technical efficiencyfl 
Organizations may be categorized as either public, private not-for-profit (NFP) or private for- 
profit (FP). Property rights theory predicts that the incentives for efficiency tend to be weaker in pub- 
lic and NFP units, which lack clear owners and cannot distribute profits. 2~z2 Profit motive is theorized 
to create a strong incentive in FP units to monitor efficiency and restrain from self-enhancing objec- 
tives such as excess staff and slack time. 2°'23'24 Empirical findings for health care organizations have 
produced varied results regarding the impact of ownership on technical efficiency. 2°'2527 
Some OSAT units are accredited by the Joint Commission on the Accreditation of Healthcare 
Organizations (JCAHO). The effect of JCAHO accreditation is to improve quality by increasing the 
probability of desired patient outcomes and to reduce the probability of undesired outcomesfl How- 
ever, becoming JCAHO accredited requires a nontrivial commitment of resources and may, there- 
fore, decrease the technical efficiency of units. 29 
Treatment organizations often offer a variety of services in concert with substance abuse treat- 
ment. The provision of these medical, educational, legal, or financial services may be utility- 
maximizing activities that account for variations in technical efficiency. The scope and intensity 
with which services are provided may reflect the goals of the organization, the requirements of reim- 
bursement agreements, or external pressure from the environment. 
There is evidence that client problems and characteristics are differentially associated with 
treatment approaches. 3° Previous research has shown that African American substance abusers 
more often suffer from more complex and multifaceted drug problemsfl '3~ In addition, clients who 
have a mental health problem in addition to their drug problem (dual diagnoses) and those clients 
who abuse more than one substance (multidrug users) are considered more complex or severe 
cases. These differences in client populations may affect technical efficiency because they often 
require additional types of treatment, special services, and coordination with other providers and 
agencies. 3~31 
Financial Factors 
Throughout the past four decades, changing financial incentives have shifted the relative costs 
and benefits of providing services, altering the delivery and management of care. 32 This study 
includes two financial factors that may affect technical efficiency: percentage of clients covered by 
insurance and percentage of revenues received in a lump sum. 
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There are a variety of public and private insurance sources that employ various mechanisms of 
reimbursement including policies based on quantity of services provided, treatment episode, or capi- 
tation. Regardless of the insurance source or the specific reimbursement policy, the resulting impact 
is price distortion for the insured client. This price distortion may negatively affect the efficiency of a 
treatment u n i t .  32 
In addition to remuneration from an insurer or a self-pay client, substance abuse units may receive 
block grants or other lump sum payments that are not directly dependent on output therapy volume. 
This type of funding may encourage more efficient treatment as OSAT units strive to maximize their 
use of this source of revenue. Alternatively, block grant funding often is linked to the specific provi- 
sion of nontreatment services such as outreach activities for vulnerable populations. Because 
resources must be allocated to these nontreatment activities and, therefore, redirected from patient 
therapy, lump sum payments may decrease the technical efficiency of the unit. 
Environmental  Factors 
Environmental factors reflect external pressures to which an organization must respond to remain 
a viable participant in the marketplace. How responsive an organization will he to environmental 
factors will depend on the competitiveness of the marketplace and the adaptability, uniqueness, and 
necessity of services provided by the organization. This study considers three environmental factors: 
intensity of nonprice competition, number of local competitors, and urban versus rural setting. 
Traditional economic theory postulates that highly competitive market structures influence pro- 
ducers to be more efficient than they would be under less competitive conditions or when assump- 
tions of a competitive marketplace are violated. 32 However, the impact of the environment may be 
more ambiguous in light of the potential nonprice competition that may exist among treatment units. 
Throughout the health care environment, nonprice competition has resulted in the supply of unnec- 
essary services and amenities among managed care groups, 33 excess capacity in hospitals, ~ and over- 
all inefficiencies in health care organizations. 35 Within the treatment environment, the manifestation 
of nonprice competition for treatment units is reflected by staff credentials, physical attractiveness 
of the treatment setting, ease of access, quality of care, marketing efforts, and the range of services 
available. 
The more treatment units there are in a market, the more incentive they have to compete, whether 
on a price or nonprice basis. All else equal, as the number of treatment units increases in a relevant 
market, the more nonprice competition becomes dominant. Also, units in rural settings have higher 
rates of excess capacity because they may have minimum staffing requirements without the consis- 
tent demand. 36 
Data Envelopment Analysis 
As with most health care organizations, outpatient substance abuse providers are multiproduct 
firms. OSAT units provide a variable mix of individual, group, and family therapies, a fact that com- 
plicates evaluation of production efficiency. Parametric analytical approaches to measuring effi- 
ciency often require a single measure of production output. To overcome this and other limitations of 
parametric approaches, data envelopment analysis (DEA) is employed to analyze production effi- 
ciency in OSAT units. 
Evaluating the efficiency of OSAT units requires the ability to identify "best practices," that is, the 
minimum set of inputs to provide therapy for a patient. Because the relationship between a unit's 
chosen inputs and outputs is complex, a method is necessary that can analyze efficiency and the 
nature of efficient relationships. 2° DEA is a nonparametric technique developed by Charnes, Cooper, 
and Rhodes that measures the rate of conversion of inputs into outputs in a multidimensional 
space. 37,38 
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The advantage of employing DEA over parametric approaches is that this technique reveals a 
level of relative technical efficiency for all units without the need to impose a production function, 
assess the marginal productivity of inputs, or gather marginal cost information for the factors or 
productsfl Another advantage to DEA is that multiple inputs and outputs may be evaluated without 
the need for those measures to be dimensionally commensurate or additive. 3s 
DEA uses linear programming methodology to define a production horizon for decision-making 
units; the standard for optimality that defines the production horizon (also referred to as the best 
practice production frontier) is derived from observed data instead of a theoretical construct. The 
mathematical model and theoretical base of DEA are described in other articlesfl ~7'4°'41 The DEA 
model employed in this study is based on the original work of Charnes, Cooper, and Rhodes that esti- 
mates a piecewise linear surface with constant returns to scale. 
For each OSAT unit, DEA measures the magnitude of departure from the production horizon 
based on the unit's use of resources to produce multiple outputsfl The DEA measure for those units 
defining the production horizon is assigned a score of 1; less efficient units are assigned a score less 
than 1 based on their relative positioning in relation to the production horizon. Therefore, those units 
that produce far fewer outputs for a given set of inputs would have a much lower DEA score than 
those units that produce closer to the best practice production frontier for a similar input 
combination. 
Reflecting the relative efficiency of each unit, these DEA scores serve as the dependent variable 




This study uses data from a 1995 national survey of OSAT units conducted by the University of 
Michigan's Institute for Social Research (ISR). To qualify for the study, at least 50% of the treatment 
services provided by these organizations must have been for drug abuse problems, and most drug- 
related services must have been provided on an outpatient basis. 
A systematic random sample of OSAT units was selected for participation from the 1994-95 
National Frame of Substance Abuse Treatment Programs (NFSATP), a national database of inpa- 
tient and OSAT programs compiled by the ISR in 1994. The national database, serving as a sampling 
frame, consists of 32,927 treatment units, making it the most complete listing available of the 
nation's OSAT unitsfl This list is a composite developed from five separate sources that were 
merged and unduplicated. These sources are as follows: 1992 National Facilities Register, 1992 
National Drug and Alcoholism Treatment Unit Survey, 1994 American Hospital Association Sur- 
vey, 1994 Food and Drug Administration list of licensed methadone providers, and a complete 
national database of businesses with a Standard Industrial Classification Code for Drug and Alcohol 
Treatment Services. 
The sample was stratified by public/private status, treatment modality (methadone or nonmetha- 
done), and organizational affiliation (e.g., hospital, mental health center). OSAT units operated by 
the Veterans Administration and by jails or prisons were excluded from the study. After screening 
and nonresponse, the total number of organizations completing interviews in 1995 was 618, for a 
combined response rate of 88%. 4: 
Some of the units in the sample provided services that were not related to substance abuse treat- 
ment. To ensure that the respective measures for the inputs and outputs were primarily dedicated to 
substance abuse treatment, only those units in which at least 75% of both clients and revenues were 
related to substance abuse treatment services are included in these analyses. This criterion permitted 
the development of an accurate and valid measure of technical efficiency as well as a way in which to 
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balance the simultaneous issues of representing the nation's outpatient treatment system and achiev- 
ing sufficient statistical power. Of the 618 units, 474 units met this criterion. The OSAT units in the 
study's national sample are small to medium-sized organizations (mean full-time equivalents = 15) 
that treat, on average, 600 clients per year. While most of the units are freestanding or unaffiliated, 
17% are affiliated with a hospital and 15% are affiliated with a mental health center. A large propor- 
tion of the organizations (62%) are private FP units. On average, sample OSAT units treat a client 
base that is 33% female and 25% African American. Clients in treatment in these organizations 
abuse a variety of drugs including heroin (average 24% of clients) and cocaine (average 22% of cli- 
ents). Additional sample characteristics are shown in Table 1. 
Survey Method 
The administrative director and clinical supervisor of each participating OSAT unit were asked to 
complete phone surveys. Directors provided information concerning the unit's ownership, environ- 
ment, finances, parent organizations, and managed care arrangements. Clinical supervisors pro- 
vided information about staff, clients, and services provided. 
Several steps were followed to produce reliable and valid phone survey data including site visits, 
two pretests of the instruments, elaborate interviewer training, extensive checks for consistency 
within and among instrument sections, and (when necessary) re-contacts with respondents. 43 
Dependent Variable 
The DEA score was used as the dependent variable in the analyses. As noted by Magnussen, 39 
reliability of the DEA score is dependent on the input and output vectors used. Therefore, to test the 
robustness of the DEA scores, various combinations of inputs and outputs were entered into the 
model, keeping the number of inputs and outputs constant. K-means rank sum test grouped the units 
by their respective efficiency level for these various input and output vectors. The ranked grouping 
into which a unit fell (five efficiency levels ranging from high to low) remained constant in 90% of 
the cases. 
Four input categories were used in the DEA model: full-time staff hours, part-time staff hours, 
consultant hours, and normalized expenditures. These inputs capture the labor and capital resources 
dedicated to the production of substance abuse therapy. Full-time staff hours and part-time staff 
hours reflect the time dedicated to the OSAT unit by employees who provide therapeutic, adminis- 
trative, or clerical services. Consultant hours capture those hours provided by external consultants or 
contractors who supplement the OSAT staff with therapeutic, administrative, or clerical services. 
Total expenditures were normalized using the Medicare operating and capital indexes for geo- 
graphic adjustment. ~ Operating and capital portions of total expenses were adjusted by either metro- 
politan statistical area (MSA) or state, depending on the location of the unit. The total normalized 
expenses capture two features of the unit's inputs. First, it captures the capital expenditures of the 
unit that are a critical part of a unit's ability to provide various services. In addition, because wages 
are normalized, those units that employ "richer" resources will have higher overall normalized 
expenses. These "richer" resources may theoretically lead to higher technical efficiency, thus adding 
valuable information to the DEA. 
Therapy hours were used to represent a quantifiable, homogeneous output in the unit's produc- 
tion function. The use of therapy hours as a measure of output is supported by other studies that show 
that some form of drug abuse counseling or psychotherapy is used in 99% of all drug treatment 
units. 4~ Three output categories were used to capture the breadth of outpatient therapy services: indi- 
vidual therapy hours, group therapy hours, and family therapy hours. Individual and family therapy 
hours per week were taken directly from the survey. Total group therapy hours per week were calcu- 
lated using group therapy hours per week per client multiplied by the number of clients per group 
session. 
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Table 1 
Sample Characteristics 
Percentage of Sample 
(N = 474) 
Affiliation 
Hospital 
Mental health center 












Have Joint Commission on the Accreditation 
of Healthcare Organizations accreditation 















(N = 474) 
Total staff (full-time equivalents) 
Total clients per year 
Number of years in business 
Mean percentage a of clients who 
Abuse heroin 
Abuse cocaine 
Abuse multiple drugs 
Have dual diagnoses 
Are women 










a. Percentages do not sum to 100 because categories are not mutually exclusive. 
Independent Variables 
A total of 21 independent variables were used in the analyses to model the relationship between 
managed care and technical efficiency. These variables may be grouped into four categories: man- 
aged care, organizational factors, financial factors, and environmental characteristics. Descriptive 
statistics and source information for each of these variables are found in Table 2; bivariate correla- 
tions are displayed in Table 3. 
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Table 2 
Explanatory Variables and Descriptive Statistics 
Standard 
Variable Range Mean Deviation 
Managed care participation 
More than 10 clients in MCAs (1 = yes) 0-1 0.37 0.48 
Managed care oversight activities 
Percentage clients for whom MCAs specify treatment plans 0-100 4.45 13.83 
Percentage clients for whom MCAs require written 
utilization review 0-100 3.98 11.88 
Percentage clients for whom MCAs require correspondence 
with treatment team 0-100 6.21 16.54 
Percentage clients for whom MCAs impose visit limits 0-100 8.56 20.10 
Percentage clients for whom MCAs impose sanctions 0-100 3.33 11.05 
Organizational factors 
Setting: Unit is affiliated with a hospital (1 = yes) 0-1 0.17 0.38 
Setting: Unit is affiliated with a mental health center (1 = yes) 0-1 0.15 0.36 
Unit provides methadone treatment (1 = yes) 0-1 0.24 0.43 
Ownership: Unit is private for-profit (1 = yes) 0-1 0.14 0.35 
Ownership: Unit is private not-for-profit (1 = yes) 0-1 0.62 0.48 
Unit has Joint Commission on the Accreditation of Healthcare 
Organizations accreditation (1 = yes) 0-1 0.22 0.42 
Intensity of nontherapy services offered by uniP 0-1615 280.59 265.59 
Client severity: Percentage clients African American 0-100 24.51 26.27 
Client severity: Percentage clients with dual diagnoses 0-100 26.91 22.01 
Client severity: Percentage clients who abuse multiple drugs 0-100 69.72 28.63 
Financial factors 
Percentage clients with some insurance (public or 
private sources) 0-100 33.45 32.94 
Percentage revenues in lump sum b 0-100 22.79 30.03 
Environmental factors 
Level of nonprice competition c 1-5 2.57 0.87 
Number of substance abuse providers in the 
county (competitors) 0-100 118.36 185.59 
Unit is in urban area (metro or fringe counties > 1 million 
population) location (1 = yes) 0-1 0.53 0.50 
NOTE: MCAs = managed care arrangements. 
a. Sum of the number of medical, social, and other support services offered (31 possible services) times average 
percentage of clients receiving each service. 
b. Lump sum payments include block grants and other special funds from government and private sources. 
c. Composite of six questions regarding extent to which competition with other units is based on issues 
other than price (staff credentials, setting, ease of access, quality of care, marketing efforts, range of treat- 
ment approaches). 
Statistical Methods 
The regression method for analyzing the determinants of efficiency followed a two-part estima- 
tion procedure. The motivation for employing this technique came from an examination of the 






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































dependent variable. The DEA scores for OSAT units that are characterized as inefficient fall into a 
wide spectrum of strictly positive values that are less than 1. Since the DEA has an upper value limit 
of  1, those OSAT units that are efficient and define the production horizon are clustered at 1.2° 
Because of  this upper bound limit at 1, the DEA score is a censored distribution. With a censored dis- 
tribution, there lacks a discriminatory score for units at the upper bound; all values above 1 are trans- 
formed to (or reported as) a single value. Consequently, a regression model other than ordinary least 
squares (OLS) is required since OLS yields asymptotically biased estimators when the dependent 
variable is censored. ~8 
The efficient units are said to be "selected" into a subsample since their respective DEA scores are 
not completely observed but instead are assigned a value of  1. Censored sample selection models 
account for the impact of  this "selection" process by modeling the process in two stages. In the first 
stage, a dichotomous variable determines whether or not the dependent variable is observed. 47 In this 
study, the first stage determines whether or not a unit is deemed relatively efficient or inefficient and 
is modeled as a probit equation. In the second stage, the expected value of  the dependent variable is 
modeled, conditional on its having been observed. 47 The correlation between the two stages is explic- 
itly modeled and is included as an explanatory variable in the second equation, which is estimated 
using OLS and includes a selection factor. 46 
To complete the two-step estimation, the Heckman procedure was applied using LIMDEP soft- 
ware (Econometric Software, Bellport, New York). Using the coding scheme required by LIMDEP, 
the inefficient units were recoded equal to 1 (those that are selected into the sample because of  com- 
plete DEA scores) and the efficient units were recoded equal to 0. 
Results 
The initial stage of  the DEA involved determination of  the relative efficiency of  the OSAT units. 
Given the distribution of the DEA variable, a dichotomous variable was created that identified units 
that were, relative to other units in the sample, the most technically efficient. Based on the DEA 
scores, 30 of  the 442* units were assigned an efficiency score of  1.00, and another 13 units were 
within the top 90% for efficiency. These 43 "efficient" units had scores ranging from 1.00 to.81, with 
a mean of.96.  The remaining 399 units had scores ranging from .79 to .02, with a mean of .3  i. The 
dichotomous efficiency variable, therefore, had 43 units with a value of  1 and 399 units with a 
value of  0. 
The Heckman model used this created dichotomous variable as the dependent variable in the 
first-stage probit model. The actual DEA score was then used as the dependent variable in the second 
stage, where the determinants of  the relative level of efficiency were evaluated. The first stage of the 
model is presented in Table 4, and the second stage of  the model is presented in Table 5. 
In the first-stage probit model, the log-likelihood ratio test (chi-square = 29.69, df= 21, p <. 1 O) 
indicated a fairly good fit to the data. Four variables in the model were statistically significant in the 
prediction of  efficient versus nonefficient OSAT units. As predicted, nonprice competition 
decreased the probability that a unit would be efficient (p < .01). The necessity of written utilization 
review also decreased the likelihood that a unit would be efficient (p < .  10). The urbanicity indicator 
was positive and significant (p < .10), suggesting that urban units were likely to have less excess 
capacity and, therefore, higher efficiency than their rural counterparts. Managed care requirements 
that require that correspondence regarding utilization review be conducted with a member of the 
treatment team also increased the likelihood that a unit was efficient (p < .05). 
* Listwise deletion of missing values reduced the sample size from 474 possible cases to approximately 442 valid Cases in 
the data envelopment analysis (DEA). Cases lost to missing items were compared to those used in the analysis, using inde- 
pendent sample t tests. Comparisons were made by strata for treatment hours per staff hours, treatment hours per clinical staff 
hours, and staffing expenditures as a percentage of total expenditures. No significant differences were found between the 
missing cases and those used in the DEA. 
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Table 4 
Results of First-Stage (PROBIT) Model: Predicting Efficient versus 
Nonefficient Outpatient Substance Abuse Treatment Units 
Variable Coefficient Standard Error 
Constant 
Managed care participation 
Managed care oversight activities 
Specify treatment plans 
Require written utilization review 
Require correspondence with treatment team 
Impose visit limits 
Impose sanctions 
Organizational factors 
Affiliated with a hospital 
Affiliated with a mental health center 
Provide methadone treatment 
Private for-profit 
Private not-for-profit 
Joint Commission on the Accreditation of Healthcare 
Organizations accreditation 
Intensity of nontherapy services 
Percentage clients African American 
Percentage clients with dual diagnoses 
Percentage clients who abuse multiple drugs 
Financial factors 
Percentage clients with some insurance 
Percentage revenues in lump sum 
Environmental factors 
Nonprice competition 
























N 435 a 
Log likelihood -120.99 
Restricted log likelihood -135.83 
Chi-square (df= 21) 29.69* 
NOTE: All values are displayed using scientific notation to improve readability. For example, "E-01" is an ab- 
breviation for the exponent field "x 10-1." 
a. Listwise deletion of missing values reduced the sample from 442 possible cases to 435 valid cases. The cases 
lost to missing items were compared to those used in the analysis using independent sample t tests. No signifi- 
cant differences were found. 
*p < .10. **p < .05. ***p < .01. 
The second stage of the selection model analyzed the efficiency for 399 units. Of the five man- 
aged care oversight procedures, only one, the imposition of sanctions, was found to have a signifi- 
cant and positive impact on the level of technical efficiency (p <.  10). The four other managed care 
Ou~atient Substance Abuse Treatment Units ALEXANDER et al. 389 
Table 5 
Results of Second-Stage (ordinary least squares) Heckman 
Estimation Model: Predicting Level of Technical Efficiency 
in Outpatient Substance Abuse Treatment Units 
Variable Coefficient Standard Error 
Constant 
Managed care participation 
Managed care oversight activities 
Specify treatment plans 
Require written utilization review 
Require correspondence with treatment team 
Impose visit limits 
Impose sanctions 
Organizational factors 
Affiliated with a hospital 
Affiliated with a mental health center 
Provide methadone treatment 
Private for-profit 
Private not-for-profit 
Joint Commission on the Accreditation of Healthcare 
Organizations accreditation 
Intensity of nontherapy services 
Percentage clients African American 
Percentage clients with dual diagnoses 
Percentage clients who abuse multiple drugs 
Financial factors 
Percentage clients with some insurance 
Percentage revenues in lump sum 
Environmental factors 
Nonprice competition 


























N 394 a 
Adjusted R 2 .05 
F(21,372) 1.92"** 
Standard error corrected for selection 0.17 
Selection criterion (rho) -0.32 
NOTE: All values are displayed using scientific notation to improve readability. For example, "E-01" is an ab- 
breviation for the exponent field "x  10-~. '' 
a. This represents only units deemed "inefficient" by the data envelopment analysis. 
*p < .10. **p < .05. ***p < .01. 
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oversight procedures and the managed care participation indicator were not found to be significantly 
associated with technical efficiency. 
As predicted, several organizational characteristics were found to make statistically significant 
contributions to the prediction of the level of technical efficiency. Affiliation with a hospital had a 
significant positive impact (/7 < .01), which may indicate that economies of scale and scope are at 
play. Units associated with hospitals may have assistance from other nonsubstance abuse depart- 
ments with support capabilities such as patient scheduling, billing, and other administrative func- 
tions. Freed from such nontherapy activities, the treatment staff may then conduct more therapy ses- 
sions, leading to relatively higher levels of efficiency. 
Affiliation with a mental health center also was positively associated with efficiency, although 
not significantly. The provision of methadone treatment significantly decreased the relative effi- 
ciency of units (p < .01). This may be explained by the method these units use to provide treatment 
for their clients. Although the administration of methadone doses involves direct patient contact, a 
unit may not classify this as patient therapy. Because the administration of methadone is considered 
a nontherapy activity, methadone units might, therefore, be less likely to provide the same relative 
therapy hours (output) for a given level of staff (input). 
FP ownership also was significantly associated with higher levels of technical efficiency (p <. 10). 
This finding, mirrored in many studies of health care organizations, may reinforce the theory of 
property rights and the incentive for these units to restrain from nontherapeutic activities. 
JCAHO accreditation significantly decreased the efficiency of a unit (p < .01). 29 As noted, 
accreditation requires a commitment on the part of the staff for nontrivial amounts of documentation 
and procedural activities. This would require additional staffing resources and, therefore, would 
decrease those committed to therapy hours. 
Financial arrangements also affected efficiency significantly. Units with higher percentages of 
insured clients were less likely to be efficient (p < .01). Insured clients might feel less restricted 
financially to demand more nontherapeutic services, higher quality, and richer staffing resources, all 
of which would decrease the technical efficiency for the unit. Revenues received in a lump sum were 
positively associated with efficiency (p <.  10). 
The only client characteristic that affected efficiency was the percentage of clients who abuse 
multiple drugs. As predicted, the existence of more clients with multiple addictions led to lower lev- 
els of technical efficiency (p < .01). These clients may require more nontherapeutic interventions 
and administrative tracking. Also, although not significant, a higher percentage of African American 
clients was associated with lower levels of efficiency, which supports previous research findings. 
None of the variables representing environmental characteristics was significantly associated 
with the relative level of technical efficiency. 
Implications for Behavioral Health Services 
Results from these analyses indicate that managed care participation is not significantly related to 
the level of efficiency of the OSAT units. This may suggest that managed care firms do not select sub- 
stance abuse treatment providers that are most efficient, nor do they create incentives for providers to 
improve the efficiency of their operations. This finding also reinforces the concern that only measur- 
ing participation in managed care might mask considerable variation in the nature of managed care 
interventions and their likely effects. Variables that allow for more detailed understanding of the 
complexity and diversity of managed care interventions, like those included in this analysis, are 
important to consider. 
Only three of the detailed measures of managed care oversight, however, are associated with 
either the likelihood of being efficient or the level of inefficiency, and two of these show weak asso- 
ciation. There are two general explanations for these results: Either (1) managed care may influence 
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provider efficiency in complex and conflicting ways or (2) managed care has not yet influenced the 
market for substance abuse treatment. 
Regarding this first potential explanation, the specific managed care oversight activities consid- 
ered have the potential to reduce organizational inputs and organizational outputs independently. For 
example, managed care oversight activities may decrease organizational inputs (treatment staff 
time) by adding to administrative work requirements. Simultaneously, managed care may stimulate 
the provider organizations to search for opportunities to reduce inefficiency through staff reductions 
and other means, which could decrease organizational outputs (therapy hours). In the organizations 
observed in this study, each of these effects may be operating simultaneously, so that no large net 
effect of managed care is observed in either direction. 
Alternatively, because they focus on reducing inappropriate use, managed care oversight proce- 
dures also have the potential to reduce client load. If this occurs, then OSAT units may correspond- 
ingly reduce inputs as they attempt to match resources with service demands. As a result of adjusting 
both inputs and outputs, organizations might not observe an improvement in either staffing ratios or 
relative technical efficiency. 
The second potential explanation, that managed care does not yet influence substance abuse treat- 
ment, is difficult to evaluate given the possibilities already cited. This study has not investigated 
whether the oversight activities are related to changes in service utilization, as has been shown to be 
the ease for general medical care services. 49 However, the fact that participation in managed care is 
not associated with improvements in technical efficiency is surprising. One would expect providers 
in managed care markets to work for the cost reductions resulting from efficiency improvements as 
purchasers begin more effectively to constrain payments for services. What is not known yet is 
whether managed care has affected the types of payment reductions for substance abuse services that 
have occurred in the general medical care sector. 
The fact that several organizational characteristics are associated with level of inefficiency in 
plausible directions lends credibility to the measure of technical efficiency in this study. These 
results also demonstrate that many of the organizational relationships found for hospitals and other 
health care providers also hold for substance abuse providers. 
FP providers had higher levels of efficiency, a finding consistent with the results of previous stud- 
ies of substance abuse providers 21 as well as of studies of hospitals, e° Whether the efficiency gains 
made by FP providers translate to reductions in prices paid and how these gains might be related to 
accessibility should be the subject of future research. 
The percentage of clients with health insurance is associated with lower efficiency. Again, this 
finding is consistent with research showing that health insurance raises prices and costs in medical 
care generally. The importance of the result here is to document that substance abuse providers 
behave in a similar fashion to other medical care providers in the presence of insurance for their 
services. 
Substance abuse units affiliated with hospitals are, on average, more efficient. This finding is at 
odds with the general perception that hospital-based units, for all types of services, are more expen- 
sive than freestanding units. What is different about this research is that it has focused on the effi- 
ciency of direct service provision rather than on reported costs. In our study, hospital-affiliated units 
employed fewer clinicians, other personnel, and other production inputs than freestanding units. But 
these same hospital-based units may report higher costs because of the overhead costs of operating 
a hospital or if employees of hospitals receive higher compensation than do workers in free- 
standing units. 
Closely related to hospital affiliation is JCAHO accreditation. 29 Accredited units are less efficient 
than those not accredited. The JCAHO accreditation program is widely accepted as increasing cost 
while bringing about some increased level of quality in the system. Results from this show that the 
cost implications of accreditation extend to substance abuse treatment units. 
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This study has several implications for managers of OSAT units. First, there is variation in techni- 
cal efficiency among OSAT providers. While there is not yet evidence that technical efficiency is a 
selection criterion used by managed behavioral care organizations, the selection criteria for partici- 
pation may become more sophisticated as managed behavioral care penetration increases. This may 
make technical efficiency an increasingly salient managerial concern. Second, managers should 
consider how specific oversight activities may affect the technical efficiency of their units when 
negotiating contracts with managed behavioral care organizations. For example, stringent utiliza- 
tion review requirements could make it difficult for units to achieve technical efficiency. 
This study also indicates that some OSAT managers might be responding to the incentives of pay- 
ment systems other than those of managed care. For example, units with large numbers of insured 
clients are somewhat less efficient, perhaps because they offer more amenities to attract insured cli- 
ents. This speculation is consistent with the finding that nonprice competition reduces the likelihood 
that a unit will operate efficiently. If managed care organizations begin to emphasize improved effi- 
ciency, then these units might find it difficult to continue offering amenities. Furthermore, those 
units accredited by the JCAHO are less efficient than nonaccredited units. In the future, managers 
might find it increasingly difficult to balance the requirements of accreditation with efficiency stan- 
dards that may be imposed by managed care. Finally, study results suggest that investor-owned units 
have been more successful in the area of technical efficiency. Accordingly, these investor-owned 
units might have an advantage over public and NFP units if managed care does place greater 
demands on OSAT units for improved efficiency. 
Limitations and Areas for Future Research 
The preceding discussion of the research findings should be tempered by the following limita- 
tions. First, technical efficiency of multiproduct firms may be measured in a variety of ways. The 
DEA score could have been constructed using other organizational inputs such as capital equipment 
or professional treatment staff hours. Similarly, the output components of the DEA score could have 
included some measure of rehabilitated clients, other quality measures, or unit recidivism rates. Sec- 
ond, the study could not consider all possible dimensions of managed behavioral care that may be 
associated with levels of technical efficiency. For example, case management activities, benefit 
package design, and the structure of provider reimbursement were not included in the current 
analysis. 
The authors' decision to exclude treatment units in which OSAT represents less than 75% of total 
clients or revenues might limit somewhat the generalizability of the findings. This criterion was 
selected to balance the issues of (1) representing the nation's OSAT system, (2) the development of 
an accurate and valid measure of the technical efficiency of OSAT units, and (3) achieving sufficient 
statistical power. It is possible, therefore, that relationships between managed care and technical 
efficiency may be different for organizations that are not  primarily dedicated to OSAT services 
including those that have changed their service offerings in response to managed care and those that 
are affiliated with mental health centers and hospitals. In general, however, the carefully constructed 
sampling frame and nationally representative sample of OSAT units suggest that the relationships 
identified in this study are likely to apply to the majority of provider organizations in the nation's out- 
patient treatment system. 
Use of DEA to estimate efficiency of production has both supporters and detractorsfl '51 The tech- 
nique can be helpful in analyzing the production of substance abuse services because the producers 
typically were providing a mix of services difficult to measure along a single dimension. Study 
results for organizational and client mix characteristics generally support the validity of the 
approach in this situation. However, the weak results for the managed care variables raise some 
doubts. As a check on the use of the DEA method, results of the DEA analysis were compared to the 
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typically were providing a mix of services difficult to measure along a single dimension. Study 
results for organizational and client mix characteristics generally support the validity of the 
approach in this situation. However, the weak results for the managed care variables raise some 
doubts. As a check on the use of the DEA method, results of the DEA analysis were compared to the 
results of analyses using more simple measures of labor productivity. In general, conclusions were 
similar.* 
While this article has shed some light on how substance abuse treatment providers are responding 
to managed care, some important questions remain unanswered. In particular, little is known about 
whether and how client programs of care are being altered because of managed care programs. Sub- 
sequent research should focus on the effects managed care might have on duration and style of treat- 
ment for substance abuse clients. 
Despite the issues just discussed, this study conlributes to the understanding of managed behav- 
ioral health care by rigorously examining the relationship between key characteristics of managed 
behavioral care and technical efficiency of OSAT providers. The use of a nationally representative 
sample, advanced analytic techniques, and multiple dimensions of managed care represent clear 
advances in this line of inquiry. 
Appendix 
Data Envelopment Models Used 
The following model was used to reveal the overall technical efficiency for each of the 442 outpa- 
tient substance abuse treatment (OSAT) units: s2 
Max Ek "~ urYr, La V~il~ 
• = 1  i = 1  
subject to the constraint: 
s m 
/ - - 1  j = l , . . . , ,  
rffil  i=1  
u• ---0 r = l  . . . . .  s 
vi _>0 i = 1  . . . . .  m 
where 
Ek = the measure ofefficiency forOSATunitk, t hememberof these to f j=  1 . . . .  442 OSATunits 
rated relative to the others; 
Yrk = the known amount of  output r produced by the OSAT unit k during the period of observa- 
tion; 
Xi~ = the known amount of input i used by the OSAT unit k during the period of observation; 
Yrj = the known amount of output r produced by the OSAT unitj during the period of observation; 
X U = the known amount of input i used by the OSAT unitj  during the period of observation; 
u• = the coefficient or weight assigned to output r computed in the solution to the data envelop- 
ment analysis (DEA) model; 
* Simple measures of labor productivity were used in place of the data envelopment analysis efficiency score in a similar 
set of analyses. These labor productivity measures, which served as dependent variables in separate analyses, included total 
professional hours per total outpatient substance abuse treatment (OSAT) therapy hours, total professional hours per individ- 
ual OSAT therapy hours, and total staff hours (professional and administrative) per total OSAT therapy hours. 
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vi = the coefficient or weight assigned to input i computed in the solution to the DEA model; 
n = the number of OSAT units; 
m = the number of inputs used by the OSAT units; and 
s = the number of  outputs produced by the OSAT units. 
The objective function of  this model maximizes the efficiency rating E for OSAT unit k. This is 
subject to the constraint that when the same set of  u and v coefficients are applied to all other OSAT 
units being compared, no OSAT unit will be more than 100% efficient and the coefficient values are 
positive. 2°,51 
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